CERS Covered Call Strategy
CERS (Cerus Corporation), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
CERS (Cerus Corporation) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $521.0M, a beta of 1.63 versus the broader market, a 52-week range of 1.15-3.15, average daily share volume of 2.1M, a public-listing history dating back to 1997, approximately 614 full-time employees. These structural characteristics shape how CERS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.63 indicates CERS has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a covered call on CERS?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current CERS snapshot
As of May 15, 2026, spot at $2.37, ATM IV 108.70%, IV rank 18.47%, expected move 31.16%. The covered call on CERS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this covered call structure on CERS specifically: CERS IV at 108.70% is on the cheap side of its 1-year range, which means a premium-selling CERS covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 31.16% (roughly $0.74 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CERS expiries trade a higher absolute premium for lower per-day decay. Position sizing on CERS should anchor to the underlying notional of $2.37 per share and to the trader's directional view on CERS stock.
CERS covered call setup
The CERS covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CERS near $2.37, the first option leg uses a $2.49 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CERS chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CERS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $2.37 | long |
| Sell 1 | Call | $2.49 | N/A |
CERS covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
CERS covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on CERS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on CERS
Covered calls on CERS are an income strategy run on existing CERS stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
CERS thesis for this covered call
The market-implied 1-standard-deviation range for CERS extends from approximately $1.63 on the downside to $3.11 on the upside. A CERS covered call collects premium on an existing long CERS position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether CERS will breach that level within the expiration window. Current CERS IV rank near 18.47% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CERS at 108.70%. As a Healthcare name, CERS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CERS-specific events.
CERS covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CERS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CERS alongside the broader basket even when CERS-specific fundamentals are unchanged. Short-premium structures like a covered call on CERS carry tail risk when realized volatility exceeds the implied move; review historical CERS earnings reactions and macro stress periods before sizing. Always rebuild the position from current CERS chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on CERS?
- A covered call on CERS is the covered call strategy applied to CERS (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With CERS stock trading near $2.37, the strikes shown on this page are snapped to the nearest listed CERS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CERS covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the CERS covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 108.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CERS covered call?
- The breakeven for the CERS covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CERS market-implied 1-standard-deviation expected move is approximately 31.16%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on CERS?
- Covered calls on CERS are an income strategy run on existing CERS stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current CERS implied volatility affect this covered call?
- CERS ATM IV is at 108.70% with IV rank near 18.47%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.